Trending stocks today
Summit Therapeutics (SMMT-Q)
NASDAQ:SMMT
21.50
0.86
(3.85%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Summit Therapeutics, identified by the ticker symbol SMMT-Q, is currently viewed with skepticism by financial experts. The prevailing sentiment indicates that the company is not making money, which raises concerns about its viability as an investment. The reviews highlight the stock's risky nature, defining it as a speculative investment rather than a stable opportunity. Potential investors are cautioned about the high level of uncertainty associated with this stock, emphasizing the need for thorough due diligence before considering any financial commitment. Overall, the combination of financial instability and speculation leads to a negative outlook from industry experts.
$21.500
Unknown
- «
- ‹
- 1
- ›
- »
Summit Therapeutics(SMMT-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 1
Summit Therapeutics(SMMT-Q) Frequently Asked Questions
What is Summit Therapeutics stock symbol?
Summit Therapeutics is a American stock, trading under the symbol SMMT-Q on the NASDAQ (SMMT). It is usually referred to as NASDAQ:SMMT or SMMT-Q
Is Summit Therapeutics a buy or a sell?
In the last year, 1 stock analyst published opinions about SMMT-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Summit Therapeutics.
Is Summit Therapeutics a good investment or a top pick?
Summit Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Summit Therapeutics.
Why is Summit Therapeutics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Summit Therapeutics worth watching?
In the last year 1 stock analyst on Stockchase covered Summit Therapeutics. The stock is worth watching.
What is Summit Therapeutics stock price?
On 2025-01-31, Summit Therapeutics (SMMT-Q) stock closed at a price of $21.5.
Doesn't make money and is a risky spec.